An investigation of reversal of imatinib resistance in the Bcr-Abl positive imatinib-resistant cell line K562r by dasatinib, nilotinib, rapamycin and bortezomib.
Xing
H
H
Department of Haematology, West China Hospital of Sichuan University, Chengdu, China.
Liu
T
T
Meng
W
W
Gong
Y
Y